脂肪组织胰岛素抵抗与脂肪组织功能障碍、循环血脂及血糖异常的纵向关联:PROMISE队列
在PROMISE队列中,468名2型糖尿病风险成人随访9年(最多4次评估),基线Adipo-IR升高与脂肪组织功能障碍、HDL降低、TG升高及血糖异常发生风险增加纵向相关,校正腰围和胰岛素抵抗替代指标后仍显著。
要点
- 基线Adipo-IR每增加1个标准差,血糖异常发生风险OR为1.59(95%CI 1.09-2.31)。
- Adipo-IR升高纵向关联脂联素下降4.20%、sCD163升高4.36%、HDL下降3.87%、TG升高9.26%。
- Adipo-IR与IL-6、TNF-α、总胆固醇、LDL无显著纵向关联。
核心结论
- 脂肪组织胰岛素抵抗可前瞻性预测脂肪组织功能障碍、HDL降低、TG升高及血糖异常发生。
研究设计与样本
- PROMISE前瞻性队列研究纳入468名2型糖尿病风险成人,9年内最多4次评估,用基线Adipo-IR评估脂肪组织胰岛素抵抗,GEE模型分析纵向关联。
主要发现
- Adipo-IR升高与脂联素下降4.20%(95%CI -6.40至-1.95)相关。
- Adipo-IR升高与sCD163升高4.36%(95%CI 1.73-7.06)相关。
- Adipo-IR升高与HDL下降3.87%(95%CI -5.15至-2.57)相关。
- Adipo-IR升高与TG升高9.26%(95%CI 5.01-13.69)相关。
- Adipo-IR每增加1个标准差,血糖异常发生风险OR为1.59(95%CI 1.09-2.31),校正腰围及胰岛素抵抗替代指标后仍显著。
临床怎么用
- 可将Adipo-IR作为识别脂肪组织功能障碍及血糖异常高风险个体的参考指标,辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the association of adipose tissue insulin resistance with longitudinal changes in biomarkers of adipose tissue function, circulating lipids, and dysglycemia. RESEARCH DESIGN AND METHODS: Adults at risk for type 2 diabetes in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort had up to four assessments over 9 years (n = 468). Adipose tissue insulin resistance was determined using a novel validated index, Adipo-IR, calculated as the product of fasting insulin and nonesterified fatty acids measured at baseline. Fasting serum was used to measure biomarkers of adipose tissue function (adiponectin and soluble CD163 [sCD163]), circulating lipids (total cholesterol, HDL, LDL, triglyceride [TG]), and systemic inflammation (interleukin-6 [IL-6] and tumor necrosis factor-α [TNF-α]). Incident dysglycemia was defined as the onset of impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes at follow-up. Generalized estimating equation (GEE) models were used to assess the relationship of Adipo-IR with longitudinal outcomes. RESULTS: GEE analyses showed that elevated Adipo-IR was longitudinally associated with adipose tissue dysfunction (adiponectin -4.20% [95% CI -6.40 to -1.95]; sCD163 4.36% [1.73-7.06], HDL -3.87% [-5.15 to -2.57], TG 9.26% [5.01-13.69]). Adipo-IR was associated with increased risk of incident dysglycemia (odds ratio 1.59 [95% CI 1.09-2.31] per SD increase). Associations remained significant after adjustment for waist circumference and surrogate indices for insulin resistance. There were no significant longitudinal associations of Adipo-IR with IL-6, TNF-α, total cholesterol, or LDL. CONCLUSIONS: Our findings demonstrate that adipose tissue insulin resistance is prospectively associated with adipose tissue function, HDL, TG, and incident dysglycemia.
引用
- Semnani-Azad Z, Connelly PW, Bazinet RP, et al. Adipose Tissue Insulin Resistance Is Longitudinally Associated With Adipose Tissue Dysfunction, Circulating Lipids, and Dysglycemia: The PROMISE Cohort. Diabetes Care. 2021. PMID: 34001534. doi:10.2337/dc20-1918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。